Lipitor sale
And, of course, there is anxiety among investors that the government might try to put a lid on prescription-drug prices to rein in medicare lipitor sale costs. Results of a study of 2,800 patients with type 2 diabetes and no history of heart lipitor sale disease, Pfizer announced, show that Lipitor was so effective compared to placebo in reducing major coronary events and stroke that the study had to be stopped early so that all patients could benefit from the drug. Cholesterol reducers were the leading class last year with $9 billion in sales. Lipitor sales in 1998 totaled approximately $2. 2 billion, which Lipitor sale more than covers the cost of the purchase price of Agouron. Managed-care companies have begun to see that it’s cost-effective. The anti-cholesterol market is one example of how a change in U. The development of a blockbuster Lipitor-Norvasc combination drug, which Pfizer and Warner-Lambert announced as a joint venture last spring, will also be allowed to go ahead as planned. Lipitor could lose patent protection as early as 2010. The acquisition will give Warner-Lambert its first FDA-approved AIDS drug, three other AIDS drugs in human testing, and experimental medicines for cancer and the common cold. Sales over the next few years may not be as hardy due to a number of patents that will expire. We Lipitor sale have begun a transformation that has been accelerated by this event. "Whilst Pfizer lipitor sale have dominated the pharmaceutical industry in recent years, the latest downturn in sales and future profit warnings from Pfizer were predicted by visiongain in our latest report – Pfizer, Current Challenges and Future Difficulties, 2005-2010. " Pfizer has not given up, and this year plans to spend a staggering $8 billion on research and development. Lipitor sale meanwhile, Warner-Lambert this year acquired Agouron Pharmaceuticals and its leading HIV drug, Viracept. Crestor is in a class of drugs known as statins, which are taken by millions around the world to control cholesterol, a major risk factor for heart disease. Parke-Davis brings considerable expertise in this area and a sales force that has extensive experience in calling on mental health professionals. WarnerLambert joins other drug makers in the hunt for new blockbuster drugs in order to maintain profit growth of more than 10 percent a year, according to reports from Bloomberg. Sales rose 15 percent to $6. 2 billion lipitor sale from $5. 4 billion as Merck lipitor sale increased drug sales. ASTRAZENECA’S cholesterol-lowering drug Crestor got unanimous backing from a US advisory panel last night, clearing a major hurdle for the company’s biggest new drug hope. Lipitor, the world’s best-selling drug, will have patent protection until at least 2009, but is producing such high revenues that the generic companies are lipitor sale itching to gain some of the market share. Ezetimibe addresses two unmet needs: provision of HMG-CoA reductase inhibition at lower statin doses and access of "difficult-to-reach" patient populations. It was the first time a generics company has challenged the core patent on a blockbuster lipitor sale medicine so far ahead of its expiry. Among the major pharmaceutical companies, Fenton said, the model that adds value looks like this: the companies own the R&D, the quality and the brand.